BPMC - Blueprint Medicines EPS beats by $0.41 beats on revenue February, 13 2020 07:10 AM Blueprint Medicines Corporation Blueprint Medicines (NASDAQ:BPMC): Q4 GAAP EPS of -$1.35 beats by $0.41.More news on: Blueprint Medicines Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...